Search Login Register

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) Summary

Description: A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.

Also Known As: Acute Lymphoblastic Leukemia; Acute Lymphocytic Leukemia; Lymphoblastic Leukemia; ALL, Childhood; Acute Lymphoid Leukemia; Leukemia, Lymphoblastic, Acute; Leukemia, Lymphoblastic, Acute, L1; Leukemia, Lymphoblastic, Acute, L2; Leukemia, Lymphoblastic, Acute, Philadelphia-Positive; Leukemia, Lymphocytic, Acute; Leukemia, Lymphocytic, Acute, L1; Leukemia, Lymphocytic, Acute, L2; Lymphoblastic Leukemia, Acute; Lymphoblastic Leukemia, Acute, Adult; Lymphoblastic Leukemia, Acute, Childhood; Lymphoblastic Leukemia, Acute, L1; Lymphoblastic Leukemia, Acute, L2; Lymphocytic Leukemia, L1; Lymphocytic Leukemia, L2; Childhood ALL; L1 Lymphocytic Leukemia; L2 Lymphocytic Leukemia; Leukemia, Acute Lymphoblastic; Leukemia, Acute Lymphocytic; Leukemia, Acute Lymphoid; Leukemia, L1 Lymphocytic; Leukemia, L2 Lymphocytic; Lymphoid Leukemia, Acute; Lymphomas, Lymphoblastic; Precursor Cell Lymphoblastic Leukemia Lymphoma; Leukemia, Lymphoblastic; Leukemia, Lymphoid, Acute; Lymphoblastic Lymphoma; Lymphocytic Leukemia, Acute; Lymphoma, Lymphoblastic

Networked: 11341 relevant articles (1119 outcomes, 1412 trials/studies) for this Disease

Key Drugs and Agents for Precursor Cell Lymphoblastic Leukemia-Lymphoma

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Methotrexate (Mexate) : 61 outcomes 99 studies in 667 results : FDA 8 Generic
  2. imatinib (Gleevec) : 59 outcomes 48 studies in 283 results : FDA 3
  3. Asparaginase (Elspar) : 44 outcomes 72 studies in 534 results : FDA 2
  4. Cytarabine (Cytosar-U) : 42 outcomes 37 studies in 297 results : FDA 13 Generic
  5. Vincristine (Oncovin) : 41 outcomes 58 studies in 331 results : FDA 17 Generic
  6. Cyclophosphamide (Cytoxan) : 34 outcomes 14 studies in 150 results : FDA 10 Generic
  7. Prednisone (Sone) : 33 outcomes 35 studies in 187 results : FDA 119 Generic
  8. 6-Mercaptopurine (Mercaptopurine) : 22 outcomes 29 studies in 218 results : FDA 4 Generic
  9. Doxorubicin (Adriamycin) : 21 outcomes 22 studies in 152 results : FDA 12 Generic
  10. dasatinib (BMS 354825) : 19 outcomes 14 studies in 107 results : FDA 2
Show All >>

Diseases Related to Precursor Cell Lymphoblastic Leukemia-Lymphoma

  1. Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
  2. Philadelphia Chromosome
  3. Leukemia
  4. BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
  5. Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
Show All >>

Key Therapies for Precursor Cell Lymphoblastic Leukemia-Lymphoma

Efficacy Chart >>
  1. Drug Therapy (Chemotherapy) : 337 outcomes 250 studies in 1924 results
  2. Bone Marrow Transplantation (Transplantation, Bone Marrow) : 124 outcomes 36 studies in 485 results
  3. Transplants (Transplant) : 95 outcomes 29 studies in 398 results
  4. Transplantation (Transplant Recipients) : 66 outcomes 27 studies in 274 results
  5. Stem Cell Transplantation : 46 outcomes 27 studies in 202 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.